Moghadam Sonia Javan, Hanks Amanda M, Keyomarsi Khandan
Department of Experimental Radiation Oncology at University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
J Carcinog. 2011;10:25. doi: 10.4103/1477-3163.90440. Epub 2011 Nov 30.
There have been numerous reviews written to date on estrogen receptor (ER), focusing on topics such as its role in the etiology of breast cancer, its mode of regulation, its role as a transcriptional activator and how to target it therapeutically, just to name a few. One reason for so much attention on this nuclear receptor is that it acts not only as a prognostic marker, but also as a target for therapy. However, a relatively undiscovered area in the literature regarding ER is how its activity in the presence and absence of ligand affects its role in proliferation and cell cycle transition. In this review, we provide a brief overview of ER signaling, ligand dependent and independent, genomic and non-genomic, and how these signaling events affect the role of ER in the mammalian cell cycle.
迄今为止,已经有大量关于雌激素受体(ER)的综述,重点关注的主题包括其在乳腺癌病因学中的作用、调节方式、作为转录激活因子的作用以及如何进行靶向治疗等等。对这种核受体如此关注的一个原因是,它不仅作为一种预后标志物,而且还是治疗靶点。然而,文献中关于ER的一个相对未被探索的领域是,其在有配体和无配体情况下的活性如何影响其在增殖和细胞周期转换中的作用。在本综述中,我们简要概述了ER信号传导,包括配体依赖性和非依赖性、基因组和非基因组信号传导,以及这些信号事件如何影响ER在哺乳动物细胞周期中的作用。